A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients
Condition(s):Fibrillary GlomerulonephritisLast Updated:October 31, 2022Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Fibrillary GlomerulonephritisLast Updated:October 31, 2022Active, not recruiting
Condition(s):Steroid-Resistant Nephrotic SyndromeLast Updated:April 23, 2019Withdrawn
Condition(s):Dermatomyositis; Juvenile DermatomyositisLast Updated:September 16, 2021Completed
Condition(s):Sarcoidosis; Cutaneous SarcoidosisLast Updated:January 28, 2015Unknown status
Condition(s):Sarcoidosis; Hypercalcemia Due to SarcoidosisLast Updated:January 26, 2015Unknown status
Condition(s):Multiple Sclerosis (MS)Last Updated:September 16, 2014Completed
Condition(s):SLE Glomerulonephritis Syndrome, WHO Class VLast Updated:May 11, 2018Withdrawn
Condition(s):Sarcoidosis, PulmonaryLast Updated:February 27, 2023Completed
Condition(s):Multiple SclerosisLast Updated:September 6, 2017Unknown status
Condition(s):Uveitis, Posterior; Vasculitis RetinalLast Updated:September 12, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.